͵ÅÄ͵¿ú

2024 ASBMB Election

GESTWICKI, Jason

Professor, University of California, San Francisco, Department of Pharmaceutical Chemistry

Jason Gestwicki

Statement of interest

The landscape of scientific publishing is undergoing exciting changes, with a push toward increased rigor, transparency and access. At the same time, changing financial incentives and increased competition have placed pressure on the system. I firmly believe that, in this new ecosystem, society journals, such as those supported by the ASBMB, continue to play a critical role.

In our journals, high-quality work, even that performed at the fringes of what is considered trendy, can be communicated in a clear and direct way to the audience(s) that will be most impacted and inspired. However, to maintain this mission, society journals will need to adapt to the changing publishing landscape, while also staying true to their core principles. What are the goals of publishing? To communicate scientific findings? To create learning opportunities for trainees? To inspire others to ask the next questions? All of these answers (and more) can be true.

My own experiences publishing in the Journal of Biological Chemistry have been rewarding because the editors, reviewers and authors have a seemingly common objective. I am pleased to be considered for the ASBMB’s Publications Committee so that I have a chance to continue the work of my predecessors in guiding our society journals.

Education and training

  • B.S., Chemistry, State University of New York at Fredonia, 1997
  • Ph.D., Biochemistry, University of Wisconsin–Madison, 2002
  • Postdoctoral training, Stanford University, 2002–2005

Awards and honors

  • National Science Foundation, 2009
  • Fellow, American Association for the Advancement of Science, 2012
  • Fellow, Cell Stress Society International, 2018
  • E. Thomas Kaiser Award, Protein Society, 2023

Experience

  • Scientific advisory board member, Chemical Biology & Drug Design, 2007–present
  • Scientific advisory board member, Journal of Medicinal Chemistry, 2012–present
  • Associate editor, ACS Chemical Biology, 2014–present
  • Scientific advisory board member, Cell Chemical Biology, 2015–present